What is Cogentin (benztropine)?
In Parkinson’s there is an imbalance between levels of dopamine and acetylcholine neurotransmitters. Cogentin helps restore balance by blocking the action of acetylcholine in the central nervous system (brain and spinal cord). Cogentin may also block the uptake and storage of dopamine in the central nervous system (CNS), resulting in the prolongation of the effects of dopamine.
Common side effects of Cogentin include:
Serious side effects of Cogentin include:
- rapid heartbeat,
- numbness of fingers,
- psychotic symptoms,
- loss of appetite,
- severe constipation,
- urinary retention,
- severe skin rash,
- blurred vision, and
- dehydration (symptoms include feeling very thirsty or hot, inability to urinate, heavy sweating, and hot and dry skin).
Drug interactions of Cogentin include:
- other anticholinergics, which increases the risk of anticholinergic side effects.
Cogentin blocks the activity of acetylcholine and can cancel or interfere with the action of drugs that increase gastrointestinal motility.
Umeclidinium and tiotropium may increase the anticholinergic side effects of Cogentin when taken together.
Safe use of Cogentin in pregnancy has not been established. Using Cogentin during pregnancy could harm a fetus.
It is not known if Cogentin is excreted in breast milk. However, antimuscarinic agents have been reported to suppress lactation in animals and decrease prolactin levels in the blood of nursing mothers. Due to the lack of safety data, Cogentin should be used cautiously in females who are breastfeeding or avoided.
What are the important side effects of Cogentin (benztropine)?
Side effects associated with benztropine treatment include:
Cogentin (benztropine) side effects list for healthcare professionals
The adverse reactions below, most of which are anticholinergic in nature, have been reported and within each category are listed in order of decreasing severity.
If dry mouth is so severe that there is difficulty in swallowing or speaking, or loss of appetite and weight, reduce dosage, or discontinue the drug temporarily.
Slight reduction in dosage may control nausea and still give sufficient relief of symptoms. Vomiting may be controlled by temporary discontinuation, followed by resumption at a lower dosage.
Toxic psychosis, including confusion, disorientation, memory impairment, visual hallucinations; exacerbation of pre-existing psychotic symptoms; nervousness; depression; listlessness; numbness of fingers.
Blurred vision, dilated pupils.
Urinary retention, dysuria.
Metabolic/Immune or Skin
Occasionally, an allergic reaction, e.g., skin rash, develops. If this cannot be controlled by dosage reduction, the medication should be discontinued.
To report SUSPECTED ADVERSE REACTIONS, contact Lundbeck Inc. at 1-800-455-1141 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Cogentin (benztropine) is an oral and injectable anticholinergic medication used to manage drug-induced extrapyramidal disorders (except tardive dyskinesia) and to treat Parkinson’s disease. Common side effects of Cogentin include skin rash, nausea, vomiting, dry mouth, tiredness, memory problems, and nervousness. Serious side effects of Cogentin include rapid heartbeat, confusion, hallucinations, depression, heat stroke, numbness of fingers, psychotic symptoms, loss of appetite, severe constipation, urinary retention, severe skin rash, blurred vision, and dehydration. Safe use of Cogentin in pregnancy has not been established. Using Cogentin during pregnancy could harm a fetus. It is not known if Cogentin is excreted in breast milk.
Multimedia: Slideshows, Images & Quizzes
Parkinson's Disease: Symptoms, Causes, Stages, Treatment
Discover the symptoms, causes, stages, and treatment options for Parkinson's disease. Learn more about the stages of Parkinson's...
Parkinson's Disease Quiz: Test Your Medical IQ
Parkinson's disease is common among neurodegenerative disorders. Do you know how it works? The causes? The symptoms? Take the...
Related Disease Conditions
Parkinson's disease is a slowly progressive neurological disease characterized by a fixed inexpressive face, a tremor at rest, slowing of voluntary movements, a gait with short accelerating steps, peculiar posture and muscle weakness, caused by degeneration of an area of the brain called the basal ganglia, and by low production of the neurotransmitter dopamine. Most patients are over 50, but at least 10 percent are under 40.
Second Source article from Government
Parkinson's Disease: Eating Right
Eating a well-balanced and nutritional diet is very beneficial to people with Parkinson's disease. With a proper diet, our bodies work more efficiently and it is especially helpful because Parkinson's disease medications will work properly.
Wolff-Parkinson-White syndrome is a condition in which abnormal electrical pathways in the heart cause arrhythmias. Symptoms of Wolff-Parkinson-White syndrome include: tachycardia, dizziness, palpitations, fainting, and shortness of breath. Wolff-Parkinson-White syndrome is a common cause of paroxysmal supraventricular tachycardia. Wolff-Parkinson-White syndrome is caused by mutations in the PRKAG2 gene.
Parkinson's Disease Clinical Trials
Before participating in a clinical trial for Parkinson's disease consider the risks and the benefits. You should know about who is eligible and what the necessary precautions are. Find out more in this article all about Parkinson's disease clinical trials.
Treatment & Diagnosis
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.